The Federal Trade Commission (FTC) is looking to take legal action against the three largest pharmacy benefit managers (PBMs) in the United States: CVS Health (CVS), UnitedHealth Group (UNH), and Cigna (CI), according to a report from The Wall Street Journal. The potential lawsuit stems from concerns over escalating drug prices and alleged anticompetitive practices, particularly for medications like insulin.

Yahoo Finance health reporter Anjalee Khemlani breaks down the details, exploring the implications for the healthcare industry, consumers, and the broader pharmaceutical market.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime.

This post was written by Angel Smith